Structure of the human protein kinase ZAK in complex with vemurafenib.
The mixed lineage kinase ZAK is a key regulator of the MAPK pathway mediating cell survival and inflammatory response. ZAK is targeted by several clinically approved kinase inhibitors, and inhibition of ZAK has been reported to protect fromdoxorubicin-induced cardiomyopathy. On the other hand, unint...
主要な著者: | Mathea, S, Abdul Azeez, K, Salah, E, Tallant, C, Wolfreys, F, Konietzny, R, Fischer, R, Lou, H, Brennan, P, Schnapp, G, Pautsch, A, Kessler, B, Turk, B, Knapp, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Chemical Society
2016
|
類似資料
-
Conformational plasticity of the ULK3 kinase domain
著者:: Mathea, S, 等
出版事項: (2021) -
Computational and Functional Analysis of Structural Features in the ZAKα Kinase
著者:: Valdemar Brimnes Ingemann Johansen, 等
出版事項: (2023-03-01) -
High-throughput purification of protein kinases from Escherichia coli and insect cells
著者:: Mathea, S, 等
出版事項: (2019) -
LA TRANSFORMADA DE ZAK
著者:: Luis Miguel Nuñez Ramirez, 等
出版事項: (2014-09-01) -
In Silico Studies of Novel Vemurafenib Derivatives as BRAF Kinase Inhibitors
著者:: Teresa Żołek, 等
出版事項: (2023-07-01)